...
首页> 外文期刊>Virology Journal >Synthetic long oligonucleotides to generate artificial templates for use as positive controls in molecular assays: drug resistance mutations in influenza virus as an example
【24h】

Synthetic long oligonucleotides to generate artificial templates for use as positive controls in molecular assays: drug resistance mutations in influenza virus as an example

机译:合成的长寡核苷酸可生成人工模板,用作分子测定中的阳性对照:以流感病毒中的耐药性突变为例

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background Positive controls are an integral component of any sensitive molecular diagnostic tool, but this can be affected, if several mutations are being screened in a scenario of a pandemic or newly emerging disease where it can be difficult to acquire all the necessary positive controls from the host. This work describes the development of a synthetic oligo-cassette for positive controls for accurate and highly sensitive diagnosis of several mutations relevant to influenza virus drug resistance. Results Using influenza antiviral drug resistance mutations as an example by employing the utility of synthetic paired long oligonucleotides containing complementary sequences at their 3' ends and utilizing the formation of oligonucleotide dimers and DNA polymerization, we generated ~170bp dsDNA containing several known specific neuraminidase inhibitor (NAI) resistance mutations. These templates were further cloned and successfully applied as positive controls in downstream assays. Conclusion This approach significantly improved the development of diagnosis of resistance mutations in terms of time, accuracy, efficiency and sensitivity, which are paramount to monitoring the emergence and spread of antiviral drug resistant influenza strains. Thus, this may have a significantly broader application in molecular diagnostics along with its application in rapid molecular testing of all relevant mutations in an event of pandemic.
机译:背景阳性对照是任何敏感的分子诊断工具不可或缺的组成部分,但是,如果在大流行或新出现疾病的情况下要筛查几个突变,可能很难从其中获得所有必要的阳性对照,那么这可能会受到影响。主办。这项工作描述了用于阳性对照的合成寡聚盒的开发,用于精确和高度灵敏地诊断与流感病毒耐药性相关的几个突变。结果以流感病毒抗病毒药物抗性突变为例,通过使用在3'端包含互补序列的合成配对长寡核苷酸的实用程序,并利用寡核苷酸二聚体的形成和DNA聚合,我们产生了约170bp的dsDNA,其中包含几种已知的特异性神经氨酸酶抑制剂( NAI)抗性突变。这些模板被进一步克隆并成功地用作下游测定中的阳性对照。结论该方法在时间,准确性,效率和敏感性方面显着改善了耐药性突变诊断的发展,这对于监测抗病毒耐药性流感病毒株的出现和传播至关重要。因此,这可能在大流行事件中在分子诊断中具有广泛的应用,并在所有相关突变的快速分子检测中具有广泛的应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号